Woodline Partners »

Hemab Therapeutics Holdings shares owned by Woodline Partners

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.5M 150k 36.73

More positions owned by Woodline Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Revolution Medicines (RVMD)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Verizon Communications (VZ)
Microchip Technology (MCHP)

View all positions for Woodline Partners

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
FMR
Capital Research and Management Company - Division 3
Deep Track Capital
Siren
venBio Select Advisor
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Driehaus Capital Management
Rock Springs Capital Management
Bellevue Group
Citadel Advisors
BlackRock

View all funds holding Hemab Therapeutics Holdings